These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 743347)

  • 1. [Microbiological quality of pharmaceutical products not mandatorily sterilized].
    Tagliapietra L
    Boll Chim Farm; 1978 Jan; 117(1):1-13. PubMed ID: 743347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiological purity of pharmaceutical forms non-necessarily sterile].
    J Pharm Belg; 1972; 27(6):670-82. PubMed ID: 4665014
    [No Abstract]   [Full Text] [Related]  

  • 4. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological investigation of officinal galenical preparations].
    Pirisino G; Piu L; Ginanneschi R
    Boll Chim Farm; 1985 Oct; 124(10):432-8. PubMed ID: 4084398
    [No Abstract]   [Full Text] [Related]  

  • 6. [The microbiological faultlessness of drugs. III. Development and problems of testing methods].
    Sagáth J; Chalabala M; Bábik I
    Cesk Farm; 1978 Oct; 27(8):353-8. PubMed ID: 743754
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical advice concerning different pharmaceutical dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2010; 80(3):121-7. PubMed ID: 21222322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of demineralized water plants through total microbial count and definition of a microbiological standard].
    Anastasio P; Burinato C; Carazzone M; Ferioli S; Genova R; Malesani L; Molinari ML; Veronese M
    Boll Chim Farm; 1985 Jun; 124(6):259-70. PubMed ID: 4063093
    [No Abstract]   [Full Text] [Related]  

  • 11. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microbiological requirements for non-compulsory sterile drugs].
    Aureli P; Pasolini B
    Boll Chim Farm; 1985 Jun; 124(6):229-43. PubMed ID: 4063090
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report.
    World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [For a strict quality of active pharmaceutical ingredients].
    Astier A
    Ann Pharm Fr; 2008 Mar; 66(2):69-70. PubMed ID: 18570901
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.